Ameditech is recalling drug abuse tests because they have shown reduced reactivity.
Source facts
Action
Ameditech Inc. sent an Urgent Medical Device Recall Letter to al affected customers on October 20, 2015, to inform them that Ameditech is recalling affected lots of Ameditech's Drugs of Abuse Tests because they have shown reduced reactivity for up to three of the nineteen Benzodiazepine (BZO) compounds. The letter informs customers of the actions to be taken. Customers were instructed to complete and return the customer verification form to (858) 677-0243 or scan and email to amt.fieldaction@alere.com. For questions regarding this recall call 858-535-1968.
Initiated
2015-10-20
Root cause
Nonconforming Material/Component
Terminated
2016-11-09
Distribution
Worldwide Distribution - US (nationwide) and Internationally to Australia.
Recall number
Z-0299-2016
Recall status
Terminated
CDRH record ID
141172
FDA record created
2015-11-18
Recall event number
72471
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.